Amrize Ltd cash flow to debt ratio of 37.39% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

Amrize Ltd's free cash flow has decreased 13.41% from $1.64B last year to $1.42B, signaling decreasing performance

Amrize Ltd's debt to equity ratio is 0.45, which means that the company's assets are healthy financed, signaling financial stability.

Amrize Ltd's debt has increased relative to shareholder equity from 0.43 last year to 0.45 today, signaling weakened financials

Amrize Ltd has a net debt to EBITDA ratio of 1.42x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Interest expense is not separately reported in Amrize Ltd's latest filing, so interest coverage cannot be calculated.

Amrize Ltd's profit margin has decreased (17.28%) in the last year from 12.12% to 10.03%, signaling decreasing performance

Amrize Ltd's short-term assets of $4.68B exceed its short-term liabilities of $2.86B

Amrize Ltd's return on assets of 4.89% is lower than the 5.00% threshold, indicating inefficient asset utilization

Amrize Ltd's return on equity of 8.94%, is lower than 15.00%, indicating bad performance

Amrize Ltd's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Amrize Ltd has insufficient public price history to evaluate earnings stability.

Amrize Ltd has positive free cash flow, indicating the company generates cash after capital expenditures

Amrize Ltd has a free cash flow yield of 5.54%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Amrize Ltd's yearly earnings has decreased 16.49% since last year from $1.42B to $1.19B, signaling decreasing performance

Amrize Ltd's yearly revenue has increased 0.95% since last year from $11.70B to $11.81B, signaling increasing performance

ROIC 6.83% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

Amrize Ltd's 3-year revenue CAGR of 3.28% is positive, indicating growing revenue over the past 3 years

Amrize Ltd has insufficient public price history to evaluate revenue consistency.

Amrize Ltd has insufficient public price history to evaluate ROE consistency.

Amrize Ltd has insufficient data to evaluate this check.

Amrize Ltd has insufficient data to evaluate this check.

Amrize Ltd is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Amrize Ltd has an EV/EBITDA ratio of 10.54x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Amrize Ltd has insufficient data to evaluate this check.

Amrize Ltd has insufficient diluted EPS history to calculate the PEG ratio.

Amrize Ltd has negative shareholder equity; price-to-book is not meaningful and the check fails

Amrize Ltd has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue